Skip to main content
. 2021 May 14;32(9):962–968. doi: 10.1097/CAD.0000000000001088

Fig. 1.

Fig. 1

Waterfall plots for the maximum percentage change from baseline in size of target lesions during the combined treatment. The dashed lines represent the criteria for progressive disease (20% increase in target lesion size) and partial response (30% decrease in target lesion size). DDP, dedifferentiated liposarcoma; MPNST, malignant peripheral nerve sheath tumor; UPS, undifferentiated pleomorphic sarcoma.